As of 3:59pm ET
| +0.04 / +0.29%|
The 7 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 24.00, with a high estimate of 33.00 and a low estimate of 18.00. The median estimate represents a +72.91% increase from the last price of 13.88.
The current consensus among 8 polled investment analysts is to Buy stock in Lexicon Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.